Skip to content
Wenlo
Sign in
← Markets

Quest Diagnostics Incorporated

Patrick Plewman (SVP for Diagnostic Services) sells DGX shares

4DGXFiled Nov 12, 2026, 7:13 PM ET· Period Nov 9, 2026

AI-generated summary

Patrick Plewman, SVP for Diagnostic Services, exercised options for 11,067 shares for $1,414,076.02 and sold 11,717 shares for $3,015,252.78. After these transactions, the insider directly held 14,684 shares of common stock. The transactions were made under a Rule 10b5-1 trading plan.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Patrick Plewman · SVP for Diagnostic Services

Rule 10b5-1 plan

DateTransactionSharesPriceValueHeld afterOwnership
Nov 9, 2026M · exercise or conversion of a derivativeFootnotes F1+4,274$127.72$545,896.6519,608Direct
Nov 9, 2026S · open-market saleFootnotes F1−4,274$257.34$1,099,871.1615,334Direct
Nov 9, 2026M · exercise or conversion of a derivativeFootnotes F1+6,793$127.81$868,179.3622,127Direct
Nov 9, 2026S · open-market saleFootnotes F1−6,793$257.34$1,748,110.6215,334Direct
Nov 9, 2026S · open-market saleFootnotes F2−650$257.34$167,271.0014,684Direct
Nov 9, 2026M · exercise or conversion of a derivativeNon-Qualifed Stock Option (right to buy)Footnotes F1, F3−4,274$127.72$545,896.650Direct
Nov 9, 2026M · exercise or conversion of a derivativeNon-Qualifed Stock Option (right to buy)Footnotes F1, F3−6,793$127.81$868,179.363,397Direct
Footnotes
  1. F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
  2. F2 The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
  3. F3 The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.

More DGX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.